Paradoxical neutrophil activation and coagulopathy during the recovery phase after endotoxemia
- PMID: 11258355
- DOI: 10.1097/00003246-200102000-00050
Paradoxical neutrophil activation and coagulopathy during the recovery phase after endotoxemia
Comment on
-
Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response.Crit Care Med. 2001 Feb;29(2):326-34. doi: 10.1097/00003246-200102000-00020. Crit Care Med. 2001. PMID: 11269245 Clinical Trial. No abstract available.
Similar articles
-
Neutrophil Activation During Septic Shock.Shock. 2018 Apr;49(4):371-384. doi: 10.1097/SHK.0000000000000980. Shock. 2018. PMID: 28858142 Review.
-
Endothelial cell dysfunction and coagulation.Crit Care Med. 2001 Jul;29(7 Suppl):S36-41. doi: 10.1097/00003246-200107001-00015. Crit Care Med. 2001. PMID: 11445732 Review.
-
Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia.Crit Care Med. 2004 May;32(5):1136-40. doi: 10.1097/01.ccm.0000126265.08175.be. Crit Care Med. 2004. PMID: 15190963 Clinical Trial.
-
Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia.Crit Care Med. 2000 May;28(5):1276-82. doi: 10.1097/00003246-200005000-00003. Crit Care Med. 2000. PMID: 10834665 Clinical Trial.
-
Nebulized anticoagulants limit pulmonary coagulopathy, but not inflammation, in a model of experimental lung injury.J Aerosol Med Pulm Drug Deliv. 2010 Apr;23(2):105-11. doi: 10.1089/jamp.2009.0779. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 20073557
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical